tissue microarrays
Immunoprofile from tissue microarrays to stratify familial breast cancer patients
15
The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays
7
Segmentation on Ovarian Cancer Tissue Microarrays using FWMS and NCuts Algorithm
7
An inexpensive method of small paraffin tissue microarrays using mechanical pencil tips
5
How to make tissue microarrays
32
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.
15
The development and validation of the Virtual Tissue Matrix, a software application that facilitates the review of tissue microarrays on line
12
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
8
The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma.
12
Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines
5
Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays
10
The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix
5
Application of in situ reverse trancriptase-polymerase chain reaction (RT-PCR) to tissue microarrays
5
In vitro tissue microarrays for quick and efficient spheroid characterisation
7
Tissue microarrays: one size does not fit all
10
Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study
7
Identification of tumor epithelium and stroma in tissue microarrays using texture analysis
11
PubMedCentral-PMC5025359.pdf
21
Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer
8
Is TIMP 1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
8